Habit Reversal Training for Children and Adolescents With Trichotillomania
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 7 - 17 |
| Updated: | 4/21/2016 |
| Start Date: | September 2011 |
| End Date: | March 2016 |
Habit Reversal Training for Children and Adolescents With Trichotillomania: A Controlled Trial
The purpose of the current study is:
1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children
ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania.
2. To explore factors that may relate to symptom severity, treatment outcome, and
psychosocial impairment (e.g., specific symptom presence, co-morbidity, emotional
regulation).
1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children
ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania.
2. To explore factors that may relate to symptom severity, treatment outcome, and
psychosocial impairment (e.g., specific symptom presence, co-morbidity, emotional
regulation).
The purpose of this research study is to further investigate how well Habit Reversal
Training (HRT) works to reduce hair-pulling symptoms in children and adolescents with
trichotillomania (TTM).
All children will have the option to receive 8 weekly HRT sessions. Half of all children
will be chosen at random to receive these sessions immediately following the pre-assessment
and the remaining half will receive them after eight weeks (TAU condition). These sessions
will focus developing skills for managing TTM and to decrease hair pulling. Such skills may
include teaching your child to replace hair-pulling with another behavior. In the TAU
condition, participants will seek the treatment in the community, with the option of
receiving HRT treatment sessions at the end of the study.
Participants in both groups will undergo four assessments in total (1) Pre-Assessment; (2)
Post-treatment Assessment; (3) One-month Follow-up; (4)Three-month Follow-up. These
assessments will involve several interviews that ask about different psychological symptoms
that your child experiences such as sadness, anxiety, and TTM.
Training (HRT) works to reduce hair-pulling symptoms in children and adolescents with
trichotillomania (TTM).
All children will have the option to receive 8 weekly HRT sessions. Half of all children
will be chosen at random to receive these sessions immediately following the pre-assessment
and the remaining half will receive them after eight weeks (TAU condition). These sessions
will focus developing skills for managing TTM and to decrease hair pulling. Such skills may
include teaching your child to replace hair-pulling with another behavior. In the TAU
condition, participants will seek the treatment in the community, with the option of
receiving HRT treatment sessions at the end of the study.
Participants in both groups will undergo four assessments in total (1) Pre-Assessment; (2)
Post-treatment Assessment; (3) One-month Follow-up; (4)Three-month Follow-up. These
assessments will involve several interviews that ask about different psychological symptoms
that your child experiences such as sadness, anxiety, and TTM.
Inclusion Criteria:
- Outpatient children between the ages of 7-17 years.
- Meets DSM-IV criteria for a primary diagnosis of TTM
- English speaking
Exclusion Criteria:
- Lifetime DSM-IV bipolar, schizophrenia, or schizoaffective disorder, or substance
abuse in past 6 months.
- A diagnosis of an autism spectrum disorders, mental retardation, or conduct disorder
- 1) Current clinically significant suicidal intent, or 2) individuals who have engaged
in suicidal behaviors within 6 months
- Receiving concurrent psychotherapy or behavioral interventions. Families will have
the option of discontinuing such services to enroll in the study. Those randomized to
treatment as usual (TAU) will be able to continue or initiate psychosocial
interventions whereas those randomized to HRT will not receive other interventions
concurrent with HRT.
- Any change in established psychotropic medication (e.g., antidepressants,
anxioloytics) within 4 weeks before study enrollment, any change in antipsychotics
within 3 weeks prior to the screening assessment, any change in fluoxetine or
atamoxetine within 6 weeks of study enrollment, and any change in alpha-2 agonists or
stimulants within 1 week of study enrollment. Those randomized to TAU may make
medication changes following randomization, including starting a medication; those
randomized to HRT will remain stable on medications during the study.
- Unwillingness of parents to make the commitment to accompany their child for multiple
study visits, unwillingness to take part in randomization, inability to attend weekly
sessions as therapist availability allows, inability to attend assessment visits.
- Presence of a significant and/or unstable medical illness which might lead to
hospitalization during the study.
We found this trial at
1
site
Click here to add this to my saved trials
